Author

Emily Sabbagh Page 5

At a comprehensive cancer center in New Haven, Connecticut, Emily Sabbagh, PharmD, BCOP, serves as an oncology clinical pharmacist. Over the past 10 years, Sabbagh has reviewed chemotherapy regimens, monitored drug interactions, and counseled patients who are beginning targeted therapies or biologics. She received her doctor of pharmacy degree from the University of North Carolina at Chapel Hill and works alongside oncologists to help manage medication side effects throughout treatment.

Ribociclib’s Mechanism of Action in Cancer Therapy Cancer
What Is the Half-Life of 5-FU and How Is It Processed?Drugs
Why Rasburicase and G6PD Deficiency Don’t Mix Drugs
What Are RAF Inhibitors and How Do They Work?Drugs
Ifosfamide Neurotoxicity: Causes, Symptoms, and Treatment Drugs
Sotorasib’s Mechanism of Action on the KRAS G12C Mutation Drugs
Elotuzumab Mechanism of Action: How the Drug Works Drugs
Difluoromethylornithine: How It Works & What It’s Used For Drugs
Fenbendazole: Mechanism, Metabolism, and Cellular Impact in Humans Drugs
Pgp Inhibitors: Their Role, Mechanisms, and Potential Drugs
Octreotide Mechanism of Action and Hormone Regulation Drugs
MMAE ADC: Chemistry, Mechanism, and Clinical Insights Drugs
Trodelvy MOA: A Detailed Look at Its Mechanism of Action Drugs
Selumetinib for Adults: Therapeutic Potential and Efficacy Drugs
Synergistic Effect of Drugs: Mechanisms and Key Factors Drugs
Enzalutamide vs Abiraterone: Mechanisms & Hormone Balance Drugs
Treosulfan: Mechanism, Pharmacokinetics, and Clinical Impact Drugs
Nivolumab vs Pembrolizumab: Mechanisms, Indications, and Reactions Drugs
Why Does Tamoxifen Cause Blood Clots? An In-Depth Look Drugs
Tyrosine Kinase Inhibitors Side Effects: Clinical Insights Drugs